Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice
IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-05-28
Data overview
- Formats
- HTML
- File languages
- English, French